Clinical Evaluation of Desoxymethasone - a new Corticosteroid.

In a double blind paired comparison study, the patients with steroid responsive dermatoses received desoxymethasone 0.25% on lesions on both sides of the body for first 4 days and desoxymethasone 0.25% on one side and 0.